OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
14
Results
Show all
Save search
Copy query
Show results for
Unknown
(14)
Publication Date
Release Date
2025
(3)
2020
(3)
2024
(2)
2026
(1)
2023
(1)
2022
(1)
2021
(1)
2018
(1)
2016
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Functionalization and antioxidant activity of polyaniline-fullerene hybrid nanomaterials: a theoretical investigation.
Not available
S-EPMC9051919
|
biostudies-literature
Cite
A thermodynamic and kinetic study of the antioxidant activity of natural hydroanthraquinones.
Not available
S-EPMC9054120
|
biostudies-literature
Cite
The antioxidant activity of natural diterpenes: theoretical insights.
Not available
S-EPMC9052119
|
biostudies-literature
Cite
2D assembled ZnO/ZnCo<sub>2</sub>O<sub>4</sub> heterostructures as efficient electrocatalysts for electrochemical detection of ofloxacin in water: experimental and DFT study.
Not available
S-EPMC12768403
|
biostudies-literature
Cite
Predictive validity of the sequential organ failure assessment score for mortality in patients with acute respiratory distress syndrome in Vietnam.
Not available
S-EPMC11876689
|
biostudies-literature
Cite
The WHO Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP) identifies high levels of ceftriaxone resistance across Vietnam, 2023.
Not available
S-EPMC11260586
|
biostudies-literature
Cite
The World Health Organization (WHO) Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP) reports continuously high levels of ceftriaxone resistance across Viet Nam, 2024.
Not available
S-EPMC12547025
|
biostudies-literature
Cite
Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA.
Not available
S-EPMC6193486
|
biostudies-literature
Cite
Multicentre prospective cohort study of body mass index and postoperative complications following gastrointestinal surgery.
Not available
S-EPMC4973675
|
biostudies-literature
Cite
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10957483
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets